A review of clinical characteristics and genetic backgrounds in Alport syndrome K Nozu, K Nakanishi, Y Abe, T Udagawa, S Okada, T Okamoto, H Kaito, ... Clinical and experimental nephrology 23, 158-168, 2019 | 235 | 2019 |
Validity of the Oxford classification of IgA nephropathy in children Y Shima, K Nakanishi, T Hama, H Mukaiyama, H Togawa, Y Hashimura, ... Pediatric nephrology 27, 783-792, 2012 | 129 | 2012 |
Spontaneous remission in children with IgA nephropathy Y Shima, K Nakanishi, T Hama, H Mukaiyama, H Togawa, M Sako, ... Pediatric Nephrology 28, 71-76, 2013 | 69 | 2013 |
Epithelial-to-mesenchymal transition in cyst lining epithelial cells in an orthologous PCK rat model of autosomal-recessive polycystic kidney disease H Togawa, K Nakanishi, H Mukaiyama, T Hama, Y Shima, M Sako, ... American Journal of Physiology-Renal Physiology 300 (2), F511-F520, 2011 | 55 | 2011 |
Common risk variants in NPHS1 and TNFSF15 are associated with childhood steroid-sensitive nephrotic syndrome X Jia, T Yamamura, R Gbadegesin, MT McNulty, K Song, Y Hitomi, D Lee, ... Kidney international 98 (5), 1308-1322, 2020 | 46 | 2020 |
Long-term outcome of childhood IgA nephropathy with minimal proteinuria A Higa, Y Shima, T Hama, M Sato, H Mukaiyama, H Togawa, R Tanaka, ... Pediatric Nephrology 30, 2121-2127, 2015 | 38 | 2015 |
Renal biopsy criterion in children with asymptomatic constant isolated proteinuria T Hama, K Nakanishi, Y Shima, H Mukaiyama, H Togawa, R Tanaka, ... Nephrology Dialysis Transplantation 27 (8), 3186-3190, 2012 | 37 | 2012 |
Biopsy timing and Oxford classification variables in childhood/adolescent IgA nephropathy Y Shima, K Nakanishi, T Hama, M Sato, H Mukaiyama, H Togawa, ... Pediatric Nephrology 30, 293-299, 2015 | 33 | 2015 |
Heterotrimeric G protein signaling in polycystic kidney disease T Hama, F Park Physiological genomics 48 (7), 429-445, 2016 | 27 | 2016 |
IgA nephropathy with presentation of nephrotic syndrome at onset in children Y Shima, K Nakanishi, M Sato, T Hama, H Mukaiyama, H Togawa, ... Pediatric Nephrology 32, 457-465, 2017 | 24 | 2017 |
TRIP13-deficient tubular epithelial cells are susceptible to apoptosis following acute kidney injury JD Pressly, T Hama, SO Brien, KR Regner, F Park Scientific reports 7 (1), 43196, 2017 | 22 | 2017 |
Renal biopsy criterion in idiopathic nephrotic syndrome with microscopic hematuria at onset T Hama, K Nakanishi, Y Shima, M Sato, H Mukaiyama, H Togawa, ... Pediatric nephrology 30, 445-450, 2015 | 19 | 2015 |
Endoplasmic reticulum stress with low-dose cyclosporine in frequently relapsing nephrotic syndrome T Hama, K Nakanishi, H Mukaiyama, Y Shima, H Togawa, M Sako, ... Pediatric Nephrology 28, 903-909, 2013 | 18 | 2013 |
A digest from evidence-based clinical practice guideline for polycystic kidney disease 2020 S Nishio, K Tsuchiya, S Nakatani, S Muto, T Mochizuki, H Kawano, ... Clinical and Experimental Nephrology 25, 1292-1302, 2021 | 13 | 2021 |
First Japanese case of Pierson syndrome with mutations in LAMB2 H Togawa, K Nakanishi, H Mukaiyama, T Hama, Y Shima, M Nakano, ... Pediatrics International 55 (2), 229-231, 2013 | 13 | 2013 |
Aberrant Smad3 phosphoisoforms in cyst-lining epithelial cells in the cpk mouse, a model of autosomal recessive polycystic kidney disease T Hama, K Nakanishi, M Sato, H Mukaiyama, H Togawa, Y Shima, ... American Journal of Physiology-Renal Physiology 313 (6), F1223-F1231, 2017 | 12 | 2017 |
Crescentic IgA nephropathy in children Y Shima, K Nakanishi, T Hama, H Mukaiyama, M Sato, Y Tanaka, ... Pediatric Nephrology 35, 1005-1014, 2020 | 9 | 2020 |
DNA damage is overcome by TRIP13 overexpression during cisplatin nephrotoxicity T Hama, PKB Nagesh, P Chowdhury, BM Moore, MM Yallapu, KR Regner, ... JCI insight 6 (22), 2021 | 6 | 2021 |
Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial) T Hama, K Nakanishi, K Ishikura, S Ito, H Nakamura, M Sako, ... BMC nephrology 19, 1-6, 2018 | 6 | 2018 |
A case of membranous nephropathy secondary to asymptomatic Graves’ disease N Moniwa, Y Shioya, Y Gocho, S Takahashi, M Tanaka, M Furuhashi, ... CEN Case Reports, 1-5, 2022 | 3 | 2022 |